Předmět:	CLINICAL trials CLINICAL drug trials DRUG efficacy DRUG tolerance TREATMENT of vascular diseases
Zdroj:	Biomedical Market Newsletter; 7/19/2012, Vol. 21, p1-3, 3p
Abstrakt:	The article offers information on the release of results for phase IIa clinical study conducted by BioInvent International AB to evaluate the effectiveness, safety and tolerance of the drug, BI-204 in treatment of atherosclerotic vascular disease. According to the results of the clinical trials, the drug showed well-tolerated response with no drug related safety signals.
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu